Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Mod Pathol. 2013 Jul 26;27(2):262–270. doi: 10.1038/modpathol.2013.146

Figure 4.

Figure 4

KRAS mutation types observed in primary pancreatic adenocarcinomas and primary lung adenocarcinomas. (a) Aminoacid mutations (b) KRAS transition (substitution of a purine for a purine or a pyrimidine for a pyrimidine) and transversion (substitution of a pyrimidine for a purine or purine for a pyrimidine) mutations.